SBAC vs STRO · P/E 30, rev $693.7M vs rev $62.0M
SBA Communications Corp (SBAC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported SBAC revenue for 2024-12-31 was $693.7M. Net income was $748.7M. Revenue was up 3.9% from 2024-09-30 to 2024-12-31. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
SBAC currently screens at market cap $24.58B and trailing P/E 30.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the SBAC and STRO stock pages for the full models.
Not investment advice.